Clinical outcomes of acute stroke patients with atrial fibrillation
Authors:
- Gregory Yh LipGLGregory Yh Lip
- 1 April 2009
- journal article
- editorial
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 7 (4) , 371-374
Abstract
Evaluation of: Kazumi K, Yasuyuki I, Kensaku S, Takeshi I, Shinji Y, Junya A. IV-tPA therapy in acute stroke patients with atrial fibrillation. J. Neurol. Sci. 276(1-2), 6-8 (2009). Stroke is the leading cause of disability and the second most common cause of death worldwide. The care and treatment of stroke patients have evolved over the last two decades, with increasing use of thrombolysis (e.g., intravenous tissue plasminogen activator in acute stroke patients), which has improved survival and recovery following stroke. The article under evaluation offers a greater insight into the relationship of clinical outcome of stroke and atrial fibrillation after tissue plasminogen activator infusion.Keywords
This publication has 21 references indexed in Scilit:
- IV t-PA therapy in acute stroke patients with atrial fibrillationJournal of the Neurological Sciences, 2009
- StrokeThe Lancet, 2008
- Stroke epidemiology in the developing worldThe Lancet, 2005
- Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsThe Lancet, 2004
- Improving the Predictive Accuracy of Recanalization on Stroke Outcome in Patients Treated With Tissue Plasminogen ActivatorStroke, 2004
- Effect of Intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed TomographyStroke, 2000
- Cost-effectiveness of tissue plasminogen activator for acute ischemic strokeNeurology, 1998
- Generalized Efficacy of t-PA for Acute StrokeStroke, 1997
- A Systems Approach to Immediate Evaluation and Management of Hyperacute StrokeStroke, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995